Back to Journals » Degenerative Neurological and Neuromuscular Disease

Degenerative Neurological and Neuromuscular Disease

ISSN: 1179-9900


Journal Articles:

- 126 records -

Effects of a Remote Multimodal Intervention Involving Diet, Walking Program, and Breathing Exercise on Quality of Life Among Newly Diagnosed People with Multiple Sclerosis: A Quasi-Experimental Non-Inferiority Pilot Study

Saxby SM, Shemirani F, Crippes LJ, Ehlinger MA, Brooks L, Bisht B, Titcomb TJ, Rubenstein LM, Eyck PT, Hoth KF, Gill C, Kamholz J, Snetselaar LG, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2024, 14:1-14

Published Date: 9 January 2024

Current Perspectives: Obesity and Neurodegeneration - Links and Risks

Kueck PJ, Morris JK, Stanford JA

Degenerative Neurological and Neuromuscular Disease 2023, 13:111-129

Published Date: 3 January 2024

Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar

Deleu D, Garcia Canibano B, Elalamy O, Sayed Abdelmoneim M, Boshra A

Degenerative Neurological and Neuromuscular Disease 2023, 13:81-88

Published Date: 13 December 2023

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation

Ma J, Hou YH, Liao ZY, Ma Z, Zhang XX, Wang JL, Zhu YB, Shan HL, Wang PY, Li CB, Lv YL, Wei YL, Dou JZ

Degenerative Neurological and Neuromuscular Disease 2023, 13:69-79

Published Date: 25 October 2023

Sexual Motivation in Persons with Multiple Sclerosis: A Controlled Cross-Sectional Study

Prinssen P, Jongen PJ, Heerings M, Wyverkens E, T'Sjoen G, Deschepper E, Dewitte M

Degenerative Neurological and Neuromuscular Disease 2023, 13:33-44

Published Date: 28 June 2023

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis

Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R

Degenerative Neurological and Neuromuscular Disease 2023, 13:21-32

Published Date: 1 February 2023

Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report

Javier-Ormazábal A, Herrero P, González-Platas M

Degenerative Neurological and Neuromuscular Disease 2023, 13:15-20

Published Date: 27 January 2023

Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far

Sivagurunathan N, Gnanasekaran Priyadharshini, Calivarathan L

Degenerative Neurological and Neuromuscular Disease 2023, 13:1-13

Published Date: 26 January 2023

Forelimb Resistance Exercise Protects Against Neuromuscular Junction Denervation in the SOD1-G93A Rat Model of ALS

Nishimune H, Stanford KG, Chen J, Odum JD, Rorie AD, Rogers RS, Wheatley JL, Geiger PC, Stanford JA

Degenerative Neurological and Neuromuscular Disease 2022, 12:145-155

Published Date: 22 November 2022

No Vitamin D Deficiency in Patients with Parkinson’s Disease

Kuhn W, Karp G, Müller T

Degenerative Neurological and Neuromuscular Disease 2022, 12:127-131

Published Date: 26 September 2022

The Wahls Behavior Change Model for Complex Chronic Diseases: A Clinician’s Guide

Elliott-Wherry AN, Lee JE, Pearlman AM, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2022, 12:111-125

Published Date: 9 September 2022

Invasive Physiotherapy as a Treatment of Spasticity: A Systematic Review

Javier-Ormazábal A, González-Platas M, González-Sierra E, González-Sierra M

Degenerative Neurological and Neuromuscular Disease 2022, 12:23-29

Published Date: 3 March 2022

The Assessment of Major Histocompatibility Complex (MHC) Class-I Expression in Different Neuromuscular Diseases

Kurdi M, Alshareef A, Bamaga AK, Fadel ZT, Alrawaili MS, Hakamy S, Mohamed F, Abuzinadah AR, Addas BM, Butt NS

Degenerative Neurological and Neuromuscular Disease 2021, 11:61-68

Published Date: 30 December 2021

Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s Disease

Labban S, Alshehri FS, Kurdi M, Alatawi Y, Alghamdi BS

Degenerative Neurological and Neuromuscular Disease 2021, 11:15-27

Published Date: 6 May 2021

Alzheimer’s Disease – Why We Need Early Diagnosis

Rasmussen J, Langerman H

Degenerative Neurological and Neuromuscular Disease 2019, 9:123-130

Published Date: 24 December 2019

Progressive Multifocal Leukoencephalopathy: Current Insights

Kartau M, Sipilä JOT, Auvinen E, Palomäki M, Verkkoniemi-Ahola A

Degenerative Neurological and Neuromuscular Disease 2019, 9:109-121

Published Date: 2 December 2019

Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone

Ghanekar SD, Miller WW, Meyer CJ, Fenelon KJ, Lacdao A, Zesiewicz TA

Degenerative Neurological and Neuromuscular Disease 2019, 9:103-107

Published Date: 15 October 2019

Sialorrhea in patients with ALS: current treatment options

Garuti G, Rao F, Ribuffo V, Sansone VA

Degenerative Neurological and Neuromuscular Disease 2019, 9:19-26

Published Date: 20 March 2019

Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy – Phase I–II

Dai A, Baspinar O, Yeşilyurt A, Sun E, İnci Aydemir C, Öztel ON, Capkan DU, Pinarli F, Agar A, Karaöz E

Degenerative Neurological and Neuromuscular Disease 2018, 8:63-77

Published Date: 26 October 2018

More articles